| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pneumocystis Infections | D016720 | 1 associated lipids |
| Corneal Endothelial Cell Loss | D055954 | 1 associated lipids |
| Male Urogenital Diseases | D052801 | 1 associated lipids |
| Trichiasis | D058457 | 1 associated lipids |
| Reproductive Tract Infections | D060737 | 1 associated lipids |
| Frontal Sinusitis | D015522 | 1 associated lipids |
| Asymptomatic Infections | D058345 | 1 associated lipids |
| Hyper-IgM Immunodeficiency Syndrome | D053306 | 1 associated lipids |
| Paratyphoid Fever | D010284 | 1 associated lipids |
| Aphasia, Broca | D001039 | 1 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wenzler S et al. | Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. | 2004 | Chemotherapy | pmid:15084805 |
| Scaglione F et al. | In vitro comparative dynamics of modified-release clarithromycin and of azithromycin. | 2000 Sep-Oct | Chemotherapy | pmid:10965100 |
| Qadri SM et al. | Antibacterial activity of azithromycin against Brucella melitensis. | 1995 Jul-Aug | Chemotherapy | pmid:7555205 |
| Braga PC and Piatti G | Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. | 1993 Nov-Dec | Chemotherapy | pmid:8222872 |
| Walkey AJ and Wiener RS | Macrolide antibiotics and survival in patients with acute lung injury. | 2012 | Chest | pmid:22116799 |
| Capitano B et al. | Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. | 2004 | Chest | pmid:15006955 |
| Drehobl MA et al. | Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults. | 2005 | Chest | pmid:16236879 |
| Milbrandt EB and Angus DC | What's in a day? | 2005 | Chest | pmid:16304247 |
| Samsa GP et al. | A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. | 2005 | Chest | pmid:16304269 |
| Paladino JA et al. | Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. | 2002 | Chest | pmid:12377852 |
| Wagner T et al. | Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. | 2005 | Chest | pmid:16100186 |
| Waterer GW et al. | Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy. | 2000 | Chest | pmid:11115489 |
| Watanabe S et al. | A 63-year-old woman with recurrent fever and productive cough. | 2012 | Chest | pmid:22396569 |
| Hodgson D et al. | The Effects of Azithromycin in Treatment-Resistant Cough: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2016 | Chest | pmid:26836927 |
| Amsden GW et al. | Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. | 2003 | Chest | pmid:12628877 |
| Wallace RJ et al. | Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. | 2014 | Chest | pmid:24457542 |
| Dean NC et al. | Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. | 2006 | Chest | pmid:16963677 |
| Noto MJ and Wheeler AP | Macrolides for acute lung injury. | 2012 | Chest | pmid:22553255 |
| Vos R et al. | Azithromycin in posttransplant bronchiolitis obliterans syndrome. | 2011 | Chest | pmid:21540223 |
| Beigelman A et al. | Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma. | 2009 | Chest | pmid:19429717 |
| Ratjen F et al. | Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. | 2012 | Chest | pmid:22595153 |
| Jarand J and Field SK | Embrace simplicity when treating lady windermere. | 2014 | Chest | pmid:25091749 |
| Luu NV et al. | Azithromycin inhibits neutrophil accumulation in airways by affecting interleukin-17 downstream signals. | 2012 | Chin. Med. J. | pmid:22490409 |
| Zhu XH et al. | Viral and Bacterial Etiology of Acute Diarrhea among Children under 5 Years of Age in Wuhan, China. | 2016 | Chin. Med. J. | pmid:27503019 |
| Fan WG et al. | Male Paraurethral Duct Infection and Subsequent Paraurethral Duct Dilation. | 2015 | Chin. Med. J. | pmid:26608997 |
| Wang D et al. | Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae. | 2009 | Chin. Med. J. | pmid:19567142 |
| Yang Z et al. | Azithromycin Causes a Novel Proarrhythmic Syndrome. | 2017 | Circ Arrhythm Electrophysiol | pmid:28408648 |
| Anderson JL et al. | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. | 1999 | Circulation | pmid:10096928 |
| Hammerschlag MR | Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. | 2002 | Circulation | pmid:12370232 |
| Gieffers J et al. | Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. | 2001 | Circulation | pmid:11157684 |
| Stone AF et al. | Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). | 2002 | Circulation | pmid:12208796 |
| Muhlestein JB et al. | Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. | 1998 | Circulation | pmid:9495296 |
| Shor A | Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection? | 2002 | Circulation | pmid:12403680 |
| Neumann FJ | Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance. | 2002 | Circulation | pmid:12417534 |
| Gupta S et al. | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. | 1997 | Circulation | pmid:9244203 |
| Parchure N et al. | Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. | 2002 | Circulation | pmid:11901039 |
| SoRelle R | Treatment with azithromycin improves endothelial function. | 2002 | Circulation | pmid:11902195 |
| Bauriedel G et al. | Azithromycin, Chlamydia pneumoniae, and intimal thickening. | 1998 | Circulation | pmid:9826328 |
| Grayston JT | Secondary prevention antibiotic treatment trials for coronary artery disease. | 2000 | Circulation | pmid:11023925 |
| Muhlestein JB et al. | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. | 2000 | Circulation | pmid:11023928 |
| Salopek-Rabatić J | Chlamydial conjunctivitis in contact lens wearers: successful treatment with single dose azithromycin. | 2001 | CLAO J | pmid:11725983 |
| Goldman MP and Longworth DL | The role of azithromycin and clarithromycin in clinical practice. | 1993 Sep-Oct | Cleve Clin J Med | pmid:8403355 |
| Alchakaki A et al. | Which patients with respiratory disease need long-term azithromycin? | 2017 | Cleve Clin J Med | pmid:28985171 |
| Giudicessi JR and Ackerman MJ | Azithromycin and risk of sudden cardiac death: guilty as charged or falsely accused? | 2013 | Cleve Clin J Med | pmid:24001961 |
| Conti CR | Antibiotics for coronary disease: it's time to move on. | 2004 | Clin Cardiol | pmid:15628106 |
| De D and Kanwar AJ | Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study. | 2011 | Clin Drug Investig | pmid:21591819 |
| Ioannidis J and Wilkinson D | HIV: opportunistic infections. | 2003 | Clin Evid | pmid:15366175 |
| Ioannidis J and Wilkinson D | HIV: prevention of opportunistic infections. | 2005 | Clin Evid | pmid:16135281 |
| Fraser-Hurt N and Mabey D | Trachoma. | 2002 | Clin Evid | pmid:12230687 |
| Low N | Chlamydia (uncomplicated, genital). | 2004 | Clin Evid | pmid:15865780 |
| Low N | Chlamydia (uncomplicated, genital). | 2006 | Clin Evid | pmid:16973080 |
| Ioannidis J and Wilkinson D | HIV: prevention of opportunistic infections. | 2003 | Clin Evid | pmid:15555123 |
| Albietz J et al. | Ocular therapeutics. | 2007 | Clin Exp Optom | pmid:17535371 |
| Opitz DL and Tyler KF | Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. | 2011 | Clin Exp Optom | pmid:21083761 |
| Ghaffariyeh A et al. | Detection of Chlamydia trachomatis in the subretinal fluid of a patient with rhegmatogenous retinal detachment. | 2011 | Clin Exp Optom | pmid:21599750 |
| Albietz J et al. | Ocular therapeutics. | 2007 | Clin Exp Optom | pmid:17311577 |
| Balci O and Gulkilik G | Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction. | 2018 | Clin Exp Optom | pmid:28677153 |
| Duff P | Antibiotic selection in obstetrics: making cost-effective choices. | 2002 | Clin Obstet Gynecol | pmid:11862059 |
| Doyle CJ et al. | Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro. | 2015 | Clin Oral Investig | pmid:24806810 |
| Jentsch HF et al. | Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole. | 2016 | Clin Oral Investig | pmid:26685849 |
| Buset SL et al. | Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs. | 2015 | Clin Oral Investig | pmid:26063646 |
| Lildholdt T et al. | The natural history of recurrent acute tonsillitis and a clinical trial of azithromycin for antibiotic prophylaxis. | 2003 | Clin Otolaryngol Allied Sci | pmid:12871256 |
| Hochreiter D et al. | Fever, severe mucositis, and conjunctivitis in a 15-year-old male. | 2012 | Clin Pediatr (Phila) | pmid:23034945 |
| Rush C and Simon MW | The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis. | 2003 | Clin Pediatr (Phila) | pmid:12862350 |
| Young TP | Banana fibers masquerading as worms in the stool of a 14-month-old girl. | 2015 | Clin Pediatr (Phila) | pmid:24803631 |
| Raszka WV et al. | Multifocal M. intracellulare osteomyelitis in an immunocompetent child. | 1994 | Clin Pediatr (Phila) | pmid:7813141 |
| Wright H et al. | Evaluating Guideline-Recommended Antibiotic Practices for Childhood Respiratory Infections: Is It Time to Consider Case-Based Formats? | 2016 | Clin Pediatr (Phila) | pmid:25986442 |
| Jensen EA et al. | Evidence-Based Pharmacologic Therapies for Prevention of Bronchopulmonary Dysplasia: Application of the Grading of Recommendations Assessment, Development, and Evaluation Methodology. | 2015 | Clin Perinatol | pmid:26593077 |
| Chandra R et al. | Clinical pharmacokinetics and gastrointestinal tolerability of a novel extended-release microsphere formulation of azithromycin. | 2007 | Clin Pharmacokinet | pmid:17328583 |
| Kuper JI and D'Aprile M | Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. | 2000 | Clin Pharmacokinet | pmid:11020135 |
| Lalak NJ and Morris DL | Azithromycin clinical pharmacokinetics. | 1993 | Clin Pharmacokinet | pmid:8287632 |
| Barve A et al. | The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans. | 2015 | Clin Pharmacol Drug Dev | pmid:27128001 |
| Ikeoka DT et al. | Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. | 2009 | Clin Res Cardiol | pmid:18853090 |
| Sandrock CE and Norris A | Infection in severe asthma exacerbations and critical asthma syndrome. | 2015 | Clin Rev Allergy Immunol | pmid:24984968 |
| Wagner VE and Iglewski BH | P. aeruginosa Biofilms in CF Infection. | 2008 | Clin Rev Allergy Immunol | pmid:18509765 |
| Leri O et al. | [Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics]. | 1997 | Clin Ter | pmid:9528197 |
| Bottaro G et al. | [Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children]. | 1994 | Clin Ter | pmid:7955949 |
| Pacor ML et al. | [Safety of azithromycin in patients allergic to penicillin and cephalosporin]. | 1994 | Clin Ter | pmid:8001336 |
| Bosatra A et al. | [Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract]. | 1994 | Clin Ter | pmid:8168348 |
| Amsden GW | Erythromycin, clarithromycin, and azithromycin: are the differences real? | 1996 Jan-Feb | Clin Ther | pmid:8851453 |
| Amin NM and Breadon G | An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. | 1995 Jul-Aug | Clin Ther | pmid:8565033 |
| Boonleang J et al. | Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. | 2007 | Clin Ther | pmid:17617293 |
| Solans A et al. | Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study. | 2008 | Clin Ther | pmid:18840369 |
| Block SL et al. | A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study. | 2005 | Clin Ther | pmid:16117986 |
| Milstone A et al. | Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis. | 2005 | Clin Ther | pmid:16117993 |
| Marple BF et al. | Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. | 2007 | Clin Ther | pmid:18201585 |
| Frank E et al. | A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. | 2002 | Clin Ther | pmid:12240780 |
| Tartaglione T | Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. | 1997 Jul-Aug | Clin Ther | pmid:9377608 |
| Mergenhagen KA et al. | Effect of azithromycin on anticoagulation-related outcomes in geriatric patients receiving warfarin. | 2013 | Clin Ther | pmid:23453406 |
| Torkildsen G and O'Brien TP | Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. | 2008 | Clin Ther | pmid:19108788 |
| Castaldo RS et al. | A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease. | 2003 | Clin Ther | pmid:12749513 |
| Holas C et al. | A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years. | 2005 | Clin Ther | pmid:16507381 |
| Piñeyro-López A et al. | Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. | 2005 | Clin Ther | pmid:16330296 |
| Kays MB and Denys GA | In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. | 2001 | Clin Ther | pmid:11318076 |
| Gupta S et al. | Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. | 2001 | Clin Ther | pmid:11318079 |
| Kingah PL et al. | Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis. | 2014 | Clin Transplant | pmid:24931185 |
| Federica M et al. | Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. | 2011 Jul-Aug | Clin Transplant | pmid:21418327 |
| Scheinfeld NS et al. | Macrolides in dermatology. | 2003 Jan-Feb | Clin. Dermatol. | pmid:12609587 |
| Fong IW et al. | Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? | 1999 | Clin. Diagn. Lab. Immunol. | pmid:10548582 |
| Trevisi P et al. | Toxic pustuloderma associated with azithromycin. | 1994 | Clin. Exp. Dermatol. | pmid:8033402 |